Literature DB >> 24583068

IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice.

Deborah L Hodge1, Cyril Berthet2, Vincenzo Coppola3, Wolfgang Kastenmüller4, Matthew D Buschman5, Paul M Schaughency6, Hidekazu Shirota7, Anthony J Scarzello8, Jeff J Subleski9, Miriam R Anver10, John R Ortaldo11, Fanching Lin12, Della A Reynolds13, Michael E Sanford14, Philipp Kaldis15, Lino Tessarollo16, Dennis M Klinman17, Howard A Young18.   

Abstract

We generated a mouse model with a 162 nt AU-rich element (ARE) region deletion in the 3' untranslated region (3'UTR) of the interferon-gamma (IFN-γ) gene that results in chronic circulating serum IFN-γ levels. Mice homozygous for the ARE deletion (ARE-Del) (-/-) present both serologic and cellular abnormalities typical of patients with systemic lupus erythematosus (SLE). ARE-Del(-/-) mice display increased numbers of pDCs in bone marrow and spleen. Addition of IFN-γ to Flt3-ligand (Flt3L) treated in vitro bone marrow cultures results in a 2-fold increase in pDCs with concurrent increases in IRF8 expression. Marginal zone B (MZB) cells and marginal zone macrophages (MZMs) are absent in ARE-Del(-/-) mice. ARE-Del(+/-) mice retain both MZB cells and MZMs and develop no or mild autoimmunity. However, low dose clodronate treatment in ARE-Del(+/-) mice specifically eliminates MZMs and promotes anti-DNA antibody development and glomerulonephritis. Our findings demonstrate the consequences of a chronic IFN-γ milieu on B220(+) cell types and in particular the impact of MZB cell loss on MZM function in autoimmunity. Furthermore, similarities between disease states in ARE-Del(-/-) mice and SLE patients suggest that IFN-γ may not only be a product of SLE but may be critical for disease onset and progression. Published by Elsevier Ltd.

Entities:  

Keywords:  Autoimmunity; Glomerulonephritis; Interferon gamma; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2014        PMID: 24583068      PMCID: PMC4148478          DOI: 10.1016/j.jaut.2014.02.003

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  47 in total

Review 1.  Recombineering: a powerful new tool for mouse functional genomics.

Authors:  N G Copeland; N A Jenkins; D L Court
Journal:  Nat Rev Genet       Date:  2001-10       Impact factor: 53.242

2.  Genetic dissection of spontaneous autoimmunity driven by 129-derived chromosome 1 Loci when expressed on C57BL/6 mice.

Authors:  Francesco Carlucci; Josefina Cortes-Hernandez; Liliane Fossati-Jimack; Anne E Bygrave; Mark J Walport; Timothy J Vyse; H Terence Cook; Marina Botto
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

Review 3.  ICSBP/IRF-8: its regulatory roles in the development of myeloid cells.

Authors:  Tomohiko Tamura; Keiko Ozato
Journal:  J Interferon Cytokine Res       Date:  2002-01       Impact factor: 2.607

4.  Predominance of Th1 immune response in diffuse proliferative lupus nephritis.

Authors:  K Masutani; M Akahoshi; K Tsuruya; M Tokumoto; T Ninomiya; T Kohsaka; K Fukuda; H Kanai; H Nakashima; T Otsuka; H Hirakata
Journal:  Arthritis Rheum       Date:  2001-09

5.  Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane.

Authors:  H B Richards; M Satoh; J C Jennette; B P Croker; H Yoshida; W H Reeves
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

6.  Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies.

Authors:  A A Bengtsson; G Sturfelt; L Truedsson; J Blomberg; G Alm; H Vallin; L Rönnblom
Journal:  Lupus       Date:  2000       Impact factor: 2.911

7.  Regulation of nuclear gamma interferon gene expression by interleukin 12 (IL-12) and IL-2 represents a novel form of posttranscriptional control.

Authors:  Deborah L Hodge; Alfredo Martinez; John G Julias; Lynn S Taylor; Howard A Young
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

8.  MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay.

Authors:  Georg Stoecklin; Tiffany Stubbs; Nancy Kedersha; Stephen Wax; William F C Rigby; T Keith Blackwell; Paul Anderson
Journal:  EMBO J       Date:  2004-03-11       Impact factor: 11.598

9.  ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells.

Authors:  Giovanna Schiavoni; Fabrizio Mattei; Paola Sestili; Paola Borghi; Massimo Venditti; Herbert C Morse; Filippo Belardelli; Lucia Gabriele
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

10.  In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon.

Authors:  C O Jacob; P H van der Meide; H O McDevitt
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

View more
  37 in total

1.  Autoimmunity and Cancer, the Paradox Comorbidities Challenging Therapy in the Context of Preexisting Autoimmunity.

Authors:  Julio C Valencia; Nkolika Egbukichi; Rebecca A Erwin-Cohen
Journal:  J Interferon Cytokine Res       Date:  2018-12-18       Impact factor: 2.607

2.  Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells.

Authors:  Fiamma Salerno; Aurelie Guislain; Julian J Freen-Van Heeren; Benoit P Nicolet; Howard A Young; Monika C Wolkers
Journal:  Oncoimmunology       Date:  2018-10-22       Impact factor: 8.110

3.  Activation Receptor-Dependent IFN-γ Production by NK Cells Is Controlled by Transcription, Translation, and the Proteasome.

Authors:  Sytse J Piersma; Melissa A Pak-Wittel; Andrea Lin; Beatrice Plougastel-Douglas; Wayne M Yokoyama
Journal:  J Immunol       Date:  2019-08-23       Impact factor: 5.422

4.  Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers.

Authors:  Catalina Lee-Chang; Monica Bodogai; Kanako Moritoh; Xin Chen; Robert Wersto; Ranjan Sen; Howard A Young; Michael Croft; Luigi Ferrucci; Arya Biragyn
Journal:  J Immunol       Date:  2016-03-16       Impact factor: 5.422

5.  The interplay of type I and type II interferons in murine autoimmune cholangitis as a basis for sex-biased autoimmunity.

Authors:  Heekyong R Bae; Deborah L Hodge; Guo-Xiang Yang; Patrick S C Leung; Sathi Babu Chodisetti; Julio C Valencia; Michael Sanford; John M Fenimore; Ziaur S M Rahman; Koichi Tsuneyama; Gary L Norman; M Eric Gershwin; Howard A Young
Journal:  Hepatology       Date:  2018-02-18       Impact factor: 17.425

6.  Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance.

Authors:  Heekyong R Bae; Patrick S C Leung; Koichi Tsuneyama; Julio C Valencia; Deborah L Hodge; Seohyun Kim; Tim Back; Megan Karwan; Anand S Merchant; Nobuyuki Baba; Dechun Feng; Ogyi Park; Bin Gao; Guo-Xiang Yang; M Eric Gershwin; Howard A Young
Journal:  Hepatology       Date:  2016-06-15       Impact factor: 17.425

Review 7.  Current prospects of type II interferon γ signaling and autoimmunity.

Authors:  Daniel S Green; Howard A Young; Julio C Valencia
Journal:  J Biol Chem       Date:  2017-06-26       Impact factor: 5.157

Review 8.  Tristetraprolin as a Therapeutic Target in Inflammatory Disease.

Authors:  Sonika Patial; Perry J Blackshear
Journal:  Trends Pharmacol Sci       Date:  2016-08-05       Impact factor: 14.819

9.  Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients.

Authors:  Kazusa Ishii; Marie Pouzolles; Christopher D Chien; Rebecca A Erwin-Cohen; M Eric Kohler; Haiying Qin; Haiyan Lei; Skyler Kuhn; Amanda K Ombrello; Alina Dulau-Florea; Michael A Eckhaus; Haneen Shalabi; Bonnie Yates; Daniel A Lichtenstein; Valérie S Zimmermann; Taisuke Kondo; Jack F Shern; Howard A Young; Naomi Taylor; Nirali N Shah; Terry J Fry
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

10.  Multi-omics: Differential expression of IFN-γ results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases.

Authors:  Heekyong R Bae; Patrick S C Leung; Deborah L Hodge; John M Fenimore; Seon-Min Jeon; Vishal Thovarai; Amiran Dzutsev; Andrew A Welcher; Michael Boedigheimer; Michael A Damore; Myung-Sook Choi; Richard A Fravell; Giorgio Trinchieri; M Eric Gershwin; Howard A Young
Journal:  J Autoimmun       Date:  2020-03-24       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.